BridgeMD
Prevention study for Intrauterine Adhesion
Official title To Evaluate the Safety and Effectiveness of Intrauterine Adhesion Preventer in the Prevention and Treatment of Intrauterine Adhesions, a Prospective, Multicenter, Randomized Controlled Clinical Trial
ClinicalTrials.gov ID: NCT07611474
What this study is testing
- What it's testing
- To evaluate the effect of uterine stents in preventing intrauterine adhesions after intrauterine operation and whether they meet the safety requirements for clinical use. The trial adopted a prospective, multicenter, randomized controlled, non-inferiority clinical trial design.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 40, women only
You may be able to join if
- Patients clinically diagnosed with intrauterine adhesions and with surgical indications (referring to those with fertility requirements or obstructed...
You likely can't join if
- ① Patients with obviously abnormal uterine cavity shape after surgery; those who could not clearly separate the normal uterine cavity anatomical...
- Those with a history of intrauterine adhesions and treatment;
- Those with endometrial tuberculosis or suspected endometrial tuberculosis;
- Those with adenomyosis or uterine fibroids\>4cm;
- Those with a history of malignant tumors or suspected malignant tumors;
- Those with acute and chronic intrauterine infection and genital infection;
See the full eligibility criteria
- Patients clinically diagnosed with intrauterine adhesions and with surgical indications (referring to those with fertility requirements or obstructed menstrual blood drainage) ② Women aged 20-40 years old; ③ people...
- ① Patients with obviously abnormal uterine cavity shape after surgery; those who could not clearly separate the normal uterine cavity anatomical morphology (i.e. bilateral or unilateral fallopian tube openings were not...
- Those with a history of intrauterine adhesions and treatment;
- Those with endometrial tuberculosis or suspected endometrial tuberculosis;
- Those with adenomyosis or uterine fibroids\>4cm;
- Those with a history of malignant tumors or suspected malignant tumors;
- Those with acute and chronic intrauterine infection and genital infection;
- Those with unexplained vaginal bleeding or suspected uterine malignant lesions;
- Those with severe anemia and abnormal coagulation function; those with a history of thrombosis; ⑨ Those in the acute stage of various diseases or severe systemic diseases;
- Those with severe mental illness and physical weakness who cannot tolerate this operation; ⑪ Those with severe heart, liver, and kidney function diseases; ⑫ Those with contraindications to anesthesia or surgery; ⑬ Those...
- Those who are considered unsuitable for inclusion by the researchers.
The study team makes the final eligibility decision.
Where it's taking place
- Changsha, Hunan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 20 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Changsha, Hunan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.